The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population
Open Access
- 7 October 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 108 (1), 54-56
- https://doi.org/10.1002/ijc.11414
Abstract
Searching for low‐penetrance genes involved in breast cancer susceptibility has been a field of interest in the last few years. Recently, the CHEK 2 gene, involved in DNA damage and replication checkpoints, has been pointed out as a good candidate; moreover, a specific variant in this gene,1100delC, has been found to increase breast cancer susceptibility among familial breast cancer cases not attributable to mutations in BRCA1 or BRCA2 genes. In our present study, we evaluated the role of the 1100delC variant as a susceptibility allele in breast cancer in the Spanish population. However, our results suggest that this variant is absent or very infrequent in our population, making its screening irrelevant from the practical point of view.Keywords
Funding Information
- Fondo de Investigación Sanitaria (FIS) (01/0024)
- Ministerio de Ciencia y Tecnologia (SAF) (01/0075)
This publication has 16 references indexed in Scilit:
- Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer SusceptibilityAmerican Journal of Human Genetics, 2003
- CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumoursBritish Journal of Cancer, 2002
- Increasing evidence that germline mutations inCHEK2do not cause Li-Fraumeni syndromeHuman Mutation, 2002
- A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerAmerican Journal of Human Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Characterization of Tumor-associated Chk2 MutationsJournal of Biological Chemistry, 2001
- hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage responseNature, 2000
- Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni SyndromeScience, 1999
- How many more breast cancer predisposition genes are there?Breast Cancer Research, 1999
- The p53 pathwayThe Journal of Pathology, 1999